Constellation Brands (NYSE:STZ) reported quarterly earnings of $2.37 per share which beat the analyst consensus estimate of $2.09 by 13.4 percent. This is a 30.22 percent increase over earnings of $1.82 per share from the same period last year. The company reported quarterly sales of $2.10 billion which beat the analyst consensus estimate of $2.02 billion by 4.11 percent. This is a 7.68 percent increase over sales of $1.95 billion the same period last year.
Inozyme Pharma Announces Peer-Reviewed Publication Revealing Increased Prevalence Of ENPP1 Deficiency
- Article in Orphanet Journal of Rare Diseases estimates genetic prevalence of ENPP1 Deficiency at 1 in 64,000 pregnancies, more than tripling prior estimate -
- Company estimates addressable